Older Adult With Heart Failure, CKD, and New NSAID Use
An 82-year-old woman (weight 62 kg) with heart failure with reduced ejection fraction (LVEF 30%), atrial fibrillation, stage 3b chronic kidney disease (baseline eGFR 42 mL/min/1.73 m²), and knee osteoarthritis presents to your community pharmacy with a 3-week history of increasing knee pain. She has been taking ibuprofen 400 mg three times daily, often with meals. Her other medications are furosemide 40 mg twice daily, ramipril 5 mg twice daily, bisoprolol 5 mg daily, spironolactone 25 mg daily, apixaban 5 mg twice daily, metformin 500 mg twice daily, and acetaminophen 500 mg as needed. Today she reports dizziness, fatigue, and 2 kg weight gain. Blood pressure is 98/60 mmHg, heart rate 58/min, and respiratory rate 18/min. Recent bloodwork: creatinine 180 μmol/L (baseline 140), eGFR 28, potassium 5.6 mmol/L, sodium 134 mmol/L. She asks whether she can take a stronger painkiller and whether her heart medicines need changing.
1. Identify the most urgent drug-related problems and explain your prioritization.
Read the worked answer
Priority 1 is the combination of daily oral ibuprofen, declining renal function, hyperkalemia, and heart failure decompensation. NSAIDs inhibit renal prostaglandins, reducing afferent arteriolar dilation; with an ACE inhibitor and spironolactone, this can cause acute kidney injury and hyperkalemia. Fluid retention has already produced a 2 kg weight gain and low blood pressure. Priority 2 is apixaban dosing: she is 82 years old and has a creatinine of 180 μmol/L, which meets two dose-reduction criteria (age ≥80 years and SCr ≥133 μmol/L); apixaban should be 2.5 mg twice daily, not 5 mg. Priority 3 is spironolactone and ramipril with K 5.6 mmol/L and eGFR 28; both increase hyperkalemia risk. Metformin should be reviewed because eGFR is now below 30 mL/min/1.73 m². Bisoprolol may contribute to dizziness and bradycardia but is not the most urgent change.
2. What immediate recommendations will you make, and what monitoring and follow-up are required?
Read the worked answer
Stop ibuprofen now. Hold spironolactone and, given AKI and hyperkalemia, hold ramipril until renal function and potassium are stable; do not simply continue both. Contact the prescriber the same day to report the AKI, K 5.6 mmol/L, and suspected NSAID contribution. Reduce apixaban to 2.5 mg twice daily if no other indication for full dose and after confirming weight and renal function. Hold metformin until eGFR is confirmed above 30. Assess volume status before changing furosemide; low BP with weight gain may reflect congestion plus hypovolemia, so clinical assessment is needed. Repeat creatinine, eGFR, potassium, and sodium within 48–72 hours. Advise sick-day rules and return precautions for oliguria, worsening dyspnea, or palpitations.
3. Recommend a safer analgesic plan and the counseling points you would provide.
Read the worked answer
Use scheduled acetaminophen up to 3 g/day (lower if hepatic risk), topical capsaicin or topical diclofenac only after assessing overall risk, heat, activity modification, and physiotherapy. Avoid oral NSAIDs. If knee pain remains severe, discuss intra-articular corticosteroid with the family physician, but ensure infection has been excluded and anticoagulation status considered. Counsel that arthritis pain does not require an oral NSAID and that combining ibuprofen with ramipril and spironolactone can harm kidneys and raise potassium. Review all OTC products for hidden NSAIDs. Follow up in 1 week and reinforce that the apixaban dose change and held medications must be confirmed with the prescriber.